Usual interstitial pneumonia complicating dyskeratosis congenita

Mayo Clinic Proceedings

Volumn 80, Issue 6, 2005, Pages 817-821

  Utz, James P ^a   Ryu, Jay H ^a   Myers, Jeffrey L ^a   Michels, Virginia V ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CORTICOSTEROID THERAPY; COUGHING; DYSKERATOSIS CONGENITA; DYSPNEA; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FUNCTION TEST; MALE; RESPIRATORY FAILURE; TREATMENT OUTCOME;

EID: 20044379963     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)61538-3     Document Type: Article

References (25)

1. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768-779.
2. Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I. Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol. 1998;103:990-996.
3. Inoue S, Mekanik G, Mahallati M, Zuelzer WW. Dyskeratosis congenita with pancytopenia: another constitutional anemia. Am J Dis Child. 1973;126:389-396.
4. Berthou C, Devergie A, D'Agay MF, et al. Late vascular complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol. 1991;79:335-336.
5. Yabe M, Yabe H, Hattori K, et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;19:389-392.
6. Ghavamzadeh A, Alimoghadam K, Nasseri P, Jahani M, Khodabandeh A, Ghahremani G. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. Bone Marrow Transplant. 1999;23:299-301.
7. Dror Y, Freedman MH, Leaker M, et al. Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita. Bone Marrow Transplant. 2003;31:847-850.
8. Rocha V, Devergie A, Socie G, et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol. 1998;103:243-248.
9. Langston AA, Sanders JE, Deeg HJ, et al. Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br J Haematol. 1996;92:758-765.
10. Nobili B, Rossi G, De Stefano P, et al. Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen [letter]. Br J Haematol. 2002;119:573-574.
11. Safa WF, Lestringant GG, Frossard PM. X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation. Thorax. 2001;56:891-894.
12. Vanbiervliet P, Blockmans D, Bobbaers H. Dyskeratosis congenita and associated interstitial lung disease: a case report. Acta Clin Belg. 1998;53:198-202.
13. Imokawa S, Sato A, Toyoshima M, et al. Dyskeratosis congenita showing usual interstitial pneumonia. Intern Med. 1994;33:226-230.
14. Paul SR, Perez-Atayde A, Williams DA. Interstitial pulmonary disease associated with dyskeratosis congenita [letter]. Am J Pediatr Hematol Oncol. Spring 1992;14:89-92.
15. Kilic S, Kose H, Ozturk H. Pulmonary involvement in a patient with dyskeratosis congenita. Pediatr Int. 2003;45:740-742.
16. Verra F, Kouzan S, Saiag P, Bignon J, de Cremoux H. Bronchoalveolar disease in dyskeratosis congenita. Eur Respir J. 1992;5:497-499.
17. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157:199-203.
18. Shay JW, Wright WE. Telomeres in dyskeratosis congenita. Nat Genet. 2004;36:437-438.
19. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413:432-435.
20. Connor JM, Gatherer D, Gray FC, Pirrit LA, Affara NA. Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet. 1986;72:348-351.
21. Devriendt K, Matthijs G, Legius E, et al. Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. Am J Hum Genet. 1997;60:581-587.
22. Scappaticci S, Fraccaro M, Cerimele D. Chromosome abnormalities in dyskeratosis congenita [letter]. Am J Med Genet. 1989;34:609-610.
23. Kehrer H, Krone W. Chromosome abnormalities in cell cultures derived from the leukoplakia of a female patient with dyskeratosis congenita. Am J Med Genet. 1992;42:217-218.
24. Kehrer H, Krone W, Schindler D, Kaufmann R, Schrezenmeier H. Cytogenetic studies of skin fibroblast cultures from a karyotypically normal female with dyskeratosis congenita. Clin Genet. 1992;41:129-134.
25. Dokal I, Bungey J, Williamson P, Oscier D, Hows J, Luzzatto L. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood. 1992;80:3090-3096.